Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: The PEDRIAL study
Authors:
- Ignacio JáureguiIJIgnacio Jáuregui
- Ignacio DávilaIDIgnacio Dávila
- Joaquín SastreJSJoaquín Sastre
- Joan BartraJBJoan Bartra
- Alfonso del CuvilloAlfonso del Cuvillo
- Marta FerrerMFMarta Ferrer
- Javier MontoroJMJavier Montoro
- Joaquim MullolJMJoaquim Mullol
- Xavier MolinaXMXavier Molina
- Antonio ValeroAVAntonio Valero
- 24 January 2011
- journal article
- research article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 22 (4) , 388-392
Abstract
To cite this article: Jáuregui I, Dávila I, Sastre J, Bartra J, del Cuvillo A, Ferrer M, Montoro J, Mullol J, Molina X, Valero A. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: The PEDRIAL study. Pediatr Allergy Immunol 2011; 22: 388–392. Allergic rhinitis (AR) is the commonest chronic disease in children. Allergic Rhinitis and its Impact on Asthma (ARIA) classification based on symptom duration (intermittent vs. persistent) and severity (mild vs. moderate/severe) has not been yet validated in children. Thus our objective was to validate ARIA classification in children, after determining the severity and duration of AR in a pediatric population, using ARIA definitions. Children aged 6–12 with a diagnosis of AR were included in an observational, cross‐sectional, multicenter study. Patients were classified according to ARIA guidelines. AR symptoms were assessed using the Total Four Symptoms Score (T4SS). Severity was also evaluated by the patient using a visual analogue scale (VAS). Comparisons were made by means of a statistical analysis. One thousand two hundred and seventy‐five children from 271 centers were included. Among them, 59.5% had intermittent and 40.5% persistent AR, while 60.7% seasonal and 39.3% perennial according to dated classification, with significant differences existing between one classification and another; 89.7% had moderate/severe rhinitis. Significantly higher T4SS and VAS scores were obtained in moderate/severe compared to mild AR. In our experience, the current ARIA classification can be considered a valid tool also in children from 6‐ to 12‐yr old.Keywords
This publication has 10 references indexed in Scilit:
- Allergic rhinitis in the child and associated comorbiditiesPediatric Allergy and Immunology, 2010
- Burden of allergic rhinitis: Results from the Pediatric Allergies in America surveyJournal of Allergy and Clinical Immunology, 2009
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*Allergy, 2008
- Rhinitis, rhinosinusitis and quality of life in childrenPediatric Allergy and Immunology, 2007
- A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity itemsJournal of Allergy and Clinical Immunology, 2007
- Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in ChildhoodPediatric Allergy and Immunology, 2007
- Severity and impairment of allergic rhinitis in patients consulting in primary careJournal of Allergy and Clinical Immunology, 2006
- Allergic rhinitis and impairment issues in schoolchildren: a consensus reportCurrent Medical Research and Opinion, 2004
- Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trialAllergy, 2003
- Validation of the classification of ARIA (allergic rhinitis and its impact on asthma)Allergy, 2003